Blue Jet Healthcare Limited Stock Price Today (NSE: BLUEJET)
Fundamental Score
Blue Jet Healthcare Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Blue Jet Healthcare Limited share price today is ₹504.55, up +0.20% on NSE/BSE as of 30 October 2026. Blue Jet Healthcare Limited (BLUEJET) is a Mid-cap company in the Pharmaceuticals sector with a market capitalisation of ₹8.75K (Cr). The 52-week high for BLUEJET share price is ₹688.50 and the 52-week low is ₹325.00. At a P/E ratio of 37.24x, BLUEJET is currently trading above its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 19.88% and a debt-to-equity ratio of 0.00.
Blue Jet Healthcare Limited Share Price Chart — NSE/BSE Historical Performance
Blue Jet Healthcare Limited share price chart: -7.86% return over the past month. 52-week high ₹688.50, 52-week low ₹325.00.
Blue Jet Healthcare Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹502.10 | ₹510.65 | ₹496.65 | ₹504.55 | 2.54L (Cr) | |
| ₹517.10 | ₹528.30 | ₹498.10 | ₹503.55 | 1.94L (Cr) | |
| ₹494.00 | ₹521.80 | ₹488.60 | ₹517.85 | 3.79L (Cr) | |
| ₹485.60 | ₹499.20 | ₹481.15 | ₹495.55 | 2.16L (Cr) | |
| ₹475.00 | ₹490.40 | ₹470.50 | ₹485.60 | 1.74L (Cr) | |
| ₹490.00 | ₹490.00 | ₹462.20 | ₹475.55 | 7.90L (Cr) | |
| ₹493.10 | ₹501.55 | ₹485.00 | ₹487.70 | 2.62L (Cr) | |
| ₹509.00 | ₹511.10 | ₹490.00 | ₹495.40 | 2.93L (Cr) | |
| ₹523.00 | ₹526.05 | ₹505.10 | ₹507.45 | 2.70L (Cr) | |
| ₹519.00 | ₹523.95 | ₹516.25 | ₹520.65 | 1.37L (Cr) |
Blue Jet Healthcare Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹538.05 | ₹549.00 | ₹462.20 | ₹504.55 | -6.23% | |
| ₹580.50 | ₹602.65 | ₹535.00 | ₹538.05 | -7.31% | |
| ₹633.00 | ₹647.80 | ₹570.25 | ₹578.75 | -8.57% | |
| ₹525.50 | ₹630.00 | ₹513.10 | ₹626.25 | +19.17% | |
| ₹449.35 | ₹547.60 | ₹434.80 | ₹525.20 | +16.88% | |
| ₹444.55 | ₹521.55 | ₹408.90 | ₹449.35 | +1.08% | |
| ₹335.00 | ₹455.00 | ₹335.00 | ₹444.55 | +32.70% | |
| ₹393.05 | ₹399.90 | ₹325.00 | ₹327.25 | -16.74% | |
| ₹410.05 | ₹453.00 | ₹352.55 | ₹405.30 | -1.16% | |
| ₹532.00 | ₹541.15 | ₹411.10 | ₹417.75 | -21.48% | |
| ₹578.40 | ₹581.05 | ₹512.40 | ₹530.20 | -8.33% | |
| ₹661.00 | ₹688.50 | ₹538.00 | ₹578.45 | -12.49% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Blue Jet Healthcare Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Blue Jet Healthcare Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of BLUEJET across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (19.88%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (26.31%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (35.18%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Consistent Growth Track Record (13.68% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (54.30x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 4.21)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Strong Cash Generation (₹572.77 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (73.15%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
High Price-to-Book Ratio (6.44x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Profit Decline Concern (-14.16%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-17.38%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Earnings Growth (-60.11% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Limited Institutional Interest (FII+DII: 4.64%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Blue Jet Healthcare Limited vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Blue Jet Healthcare Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Blue Jet Healthcare LimitedBlue Jet Health...Selected✓ BLUEJET • 544009 | 41.3/100 | ₹504.55₹505 | ₹8752.18₹8752.18 | 37.24Average 37.2 Average | 19.88%Good 19.88% Good | 26.31%Excellent 26.31% Excellent | 0.00Excellent 0.0 Excellent | 12.07%Good 12.07% Good | 13.68%Good 13.68% Good | 0.20% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 72.9/100 | ₹1758.80₹1759 | ₹421988.88₹421988.88 | 34.90Average 34.9 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 67.2/100 | ₹9144.50₹9145 | ₹242329.25₹242329.25 | 82.97Average 83.0 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 54.8/100 | ₹4558.90₹4559 | ₹154300.53₹154300.53 | 72.83Average 72.8 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 71.6/100 | ₹1123.00₹1123 | ₹112075.40₹112075.40 | 25.03Average 25.0 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 53.5/100 | ₹2060.10₹2060 | ₹111296.90₹111296.90 | 101.68Average 101.7 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 35.2/100 | ₹1325.10₹1325 | ₹107048.20₹107048.20 | 31.75Average 31.7 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 36.5/100 | ₹1233.00₹1233 | ₹102955.50₹102955.50 | 31.87Average 31.9 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1666.90₹1667 | ₹95913.43₹95913.43 | 26.05Average 26.0 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 59.7/100 | ₹2275.50₹2276 | ₹93978.15₹93978.15 | 45.98Average 46.0 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 77.1/100 | ₹1961.60₹1962 | ₹89694.16₹89694.16 | 16.21Average 16.2 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price421988.88 Cr
- Divi's Laboratories Limited share price242329.25 Cr
- Torrent Pharmaceuticals Limited share price154300.53 Cr
- Zydus Lifesciences Limited share price112075.40 Cr
- Laurus Labs Limited share price111296.90 Cr
Blue Jet Healthcare Limited PE Ratio History
Historical price-to-earnings ratio for BLUEJET — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹17.59 | ₹530.20 | 30.1x |
| FY 2024 | ₹9.44 | ₹564.70 | 59.8x |
| FY 2023 | ₹9.23 | ₹368.10 | 39.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Blue Jet Healthcare Limited Dividend History
Annual cash dividends paid by BLUEJET — dividend yield 0.20%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹17.35 Cr |
| FY 2024 | ₹0.00 Cr |
| FY 2023 | ₹0.00 Cr |
| FY 2022 | ₹0.00 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Blue Jet Healthcare Limited Quarterly Performance
Latest quarterly metrics for BLUEJET — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-17.38%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-14.16%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
13.68%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
12.07%
Compounded annual net profit growth over 5 years
Blue Jet Healthcare Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for BLUEJET — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
Blue Jet Healthcare Limited Financial Statements
Annual income statement, balance sheet and cash flow for Blue Jet Healthcare Limited (BLUEJET) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Blue Jet Healthcare Limited
About BLUEJET (Blue Jet Healthcare Limited)
Blue Jet Healthcare Ltd is a dynamic force in the pharmaceutical landscape, specializing in the intricate art of crafting high-value pharmaceutical intermediates and active pharmac...eutical ingredients (APIs). Their expertise lies in developing and manufacturing complex molecules that serve as essential building blocks for a wide spectrum of therapeutic applications. Beyond simple production, Blue Jet prides itself on mastering challenging chemistries and navigating the complexities of regulatory compliance, ensuring the quality and purity of its products. They are committed to driving innovation within the pharmaceutical supply chain by delivering specialized intermediates and APIs that empower drug manufacturers to create life-enhancing medications. The company’s core strength stems from its dedication to precision and customization. Blue Jet not only provides established pharmaceutical building blocks but also excels in the development of niche intermediates tailored to the unique needs of its clients. This involves a deep understanding of the evolving demands of the pharmaceutical industry and a commitment to staying ahead of the curve with innovative manufacturing processes. Their focus on customized solutions extends to offering comprehensive support throughout the drug development lifecycle, from early-stage research to large-scale commercial production, forging strong and lasting partnerships with pharmaceutical companies. With a focus on excellence and an unwavering commitment to quality, Blue Jet Healthcare aims to be a reliable and trusted partner for pharmaceutical companies worldwide. They are committed to ensuring the consistent delivery of high-quality pharmaceutical intermediates and APIs that meet stringent regulatory requirements. The company’s drive for continuous improvement in manufacturing processes, combined with a strong dedication to customer satisfaction, positions them as a forward-thinking player in the pharmaceutical industry. By focusing on innovation and reliability, Blue Jet Healthcare is dedicated to contributing to the advancement of healthcare solutions globally.
Company Details
Key Leadership
BLUEJET Share Price: Frequently Asked Questions
What is the current share price of Blue Jet Healthcare Limited?
Blue Jet Healthcare Limited (BLUEJET) trades at ₹504.55 on NSE and BSE. Market cap ₹8.75K (Cr). Educational data only.
What is the P/E ratio of Blue Jet Healthcare Limited?
Blue Jet Healthcare Limited has a P/E of 37.24x vs industry average 34.89x.
What is the Bull Run score for Blue Jet Healthcare Limited?
Blue Jet Healthcare Limited has a Bull Run score of 41.3/100 based on 25+ financial parameters.
Does Blue Jet Healthcare Limited pay dividends?
Blue Jet Healthcare Limited has a dividend yield of 0.20%. Past dividends don't guarantee future payments.
What is the ROE of Blue Jet Healthcare Limited?
Blue Jet Healthcare Limited has ROE of 19.88%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Blue Jet Healthcare Limited?
Blue Jet Healthcare Limited has debt-to-equity of 0.00.
Is Blue Jet Healthcare Limited a good investment?
Bull Run gives Blue Jet Healthcare Limited a score of 41.3/100. This is not investment advice — consult a SEBI-registered advisor.